Top pharmaceutical sales company Vanguard Pharmaceuticals has the possibility of acquiring the sales contact for the recently developed swine flu vaccine.

swine-flu1The swine flu virus has spread into a worldwide pandemic and with top Biotech companies recently developing a swine flu vaccine; Vanguard Pharmaceuticals have the opportunity to provide sales efforts in order to distribute the vaccine on behalf of swine flu virus manufacturers.

Vanguard Pharmaceuticals have had previous success in sales contracts with Sanofi to sustain interest in the mature products as well as Solvay to support other sales-force efforts.

Swine Flu Vaccination has begun in several countries including Australia and the U.K; the US and Europe are nearing vaccination programs with late stage trials.

With top biotech companies including GlaxoSmithKline (GSK), Novavax (NVX) and Astra Zeneca (AZN) on the brink of discovering a commercial swine flu vaccine, Vanguard Pharmaceutical’s is showing promising signs of being contracted to provide their experience and knowledge for sales and marketing solutions in respect to the swine flu vaccine.